Skip to main content

Table 1 Study assessment schedule

From: Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation

Assessments Screening Baseline 12-week follow-up 24-week follow-up 52-week follow-up
Structured Clinical Interview for DSM-IV Axis II Personality disorders X - - - -
Structured Clinical Interview for DSM-IV (SCID-I)a X - - - -
Hypomanic Checklist X - - - -
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) X - - - X
Morisky scale - - X X X
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) - X X X X
Beck Depression Inventory - X X X X
Acts of Deliberate Self Harm - X X X X
Social Functioning Scale - X X X X
EuroQoL-5D - X X X X
Side Effect Scale - X X X X
Modified Adult Service User Schedule - X X X X
  1. DSM-IV Diagnostic and Statistical Manual of Mental Disorders (4th edition), EuroQoL-5D European quality of Life-5 dimensions
  2. aSection on bipolar affective disorder (type I and II)